(Q41521938)

2 October 2017

1 reference

title

Recent advances in the discovery and development of topoisomerase inhibitors as antitumor agents (English)

1 reference

2 October 2017

Wang HK

1

1 reference

PubMed ID

9211397

2 October 2017

Morris-Natschke SL

series ordinal

2

1 reference

PubMed ID

9211397

2 October 2017

Lee KH

series ordinal

3

1 reference

2 October 2017

1 July 1997

1 reference

Medicinal Research Reviews

2 October 2017

1 reference

2 October 2017

17

1 reference

2 October 2017

4

1 reference

2 October 2017

367-425

1 reference

Phase I and pharmacological study of the new topoisomerase I inhibitor GI147211, using a daily x 5 intravenous administration

2 October 2017

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1128%28199707%2917%3A4%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-U

ED-110, a novel indolocarbazole, prevents the growth of experimental tumors in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1128%28199707%2917%3A4%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-U

Topoisomerases, new targets in cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1128%28199707%2917%3A4%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-U

Menogaril, an anthracycline derivative, inhibits DNA topoisomerase II by stabilizing cleavable complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1128%28199707%2917%3A4%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-U

Synthesis and mode(s) of action of a new series of imide derivatives of 3-nitro-1,8 naphthalic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1128%28199707%2917%3A4%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-U

Netropsin and bis-netropsin analogs as inhibitors of the catalytic activity of mammalian DNA topoisomerase II and topoisomerase cleavable complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1128%28199707%2917%3A4%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-U

Inhibition of topoisomerase II by a novel antitumor cyclic depsipeptide, BE-22179.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1128%28199707%2917%3A4%3C367%3A%3AAID-MED3%3E3.0.CO%3B2-U

Terpentecin and UCT4B, New Family of Topoisomerase II Targeting Antitumor Antibiotics Produced by Streptomyces: Producing Organism, Frementation and Large Scale Purification.

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.48.211

Clerocidin, a terpenoid antibiotic, inhibits bacterial DNA gyrase

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.46.526

Saintopin, a new antitumor antibiotic with topoisomerase II dependent DNA cleavage activity, from Paecilomyces

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.43.1344

Ravidomycin (AY-25,545), a new antitumor antibiotic.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.36.355

The chemistry of the antibiotics chrysomycin A and B. Antitumor activity of chrysomycin A.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.35.1194

Identifiers

DOI

10.1002/(SICI)1098-1128(199707)17:4<367::AID-MED3>3.0.CO;2-U

1 reference

2 October 2017

1 reference

PubMed ID

9211397